维普中文期刊产品整合服务
24篇 您的检索式:作者名="FOUNTZILAS E"
    题名 作者 年代 出处 被引量
1Induction chemotherapyfollowed by concomitant radiotherapy and weekly cisplatin versusthe sameconcomitant chemoradiotherapy in patients with nasopha-ryngeal carcinoma: a randomized phase II studyconducted by theHellenic Cooperative Oncology Group (HeCOG) with biomarkerevaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Arm Oncol2012,23,2:1
2Keapl mutations and Nrf2 pathway activation in epithelial ovarian cancer 显示文摘KONSTANTINOPOULOS PA SPENTZOS D FOUNTZILAS E 2011Cancer Res2011,71,15:1
3Keapl mutations and Nrf2 pathway activation in epithelial? ovarian cancer显示文摘Konstantinopoulos PA Spentzos D Fountzilas E 2011Cancer Res2011,71,15:1
4Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemora- diotherapy in patients with nasopharyngeal carcinoma:a randomized phase 11 study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation 显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
5Keapl mutations and Nrf2 pathway activation in epithelial ovarian cancer显示文摘Konstantinopoulos PA Spentzos D Fountzilas E 2011Cancer Res2011,71,15:1
6Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma:a randomized phase II study conducted by the Hellenic Cooperative Oncology Group(HeCOG)with biomarker evaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Annals of oncology2012,23,2:1
7Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma:a randomized phase II study conducted by the Hellenic Cooperative Oncology Group(He COG)with biomarker evaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
8Concomitant radi-ochemotherapy vs radiotherapy alone in patients with head and neck cancer:a Hellenic Cooperative Oncology Group Phase Ⅲ Study显示文摘Fountzilas G Ciuleanu E Dafni U 2004Med Oncol2004,21,2:1
9Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma:a randomized phase Ⅱ study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,:1
10Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopha- ryngeal carcinoma: a randomized phase H study conducted by the Hellenic Cooperatiye Oncology Group (HeCOG) with biomarker e- valuation 显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
11Evaluation of the incidence and prognostic value of mutant epidermal growth factor receptor(EGFRvIII)protein expression in head and neck squamous cell carcinomas(HNSCC)using AQUA显示文摘PECTASIDES E FOUNTZILAS G KOUNTOURAKIS P 2010ASCO Meeting Abstracts2010,28,:1
12Continuation of trastu- zumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of SO cases by the hellenic cooperative oncology group 显示文摘Fountzilas G Razis E Tsavdaridis D 2003Clin Breast Cancer2003,4,2:1
13Induction chemothera-py followed by concomitant radiotherapy and weekly cisplatin ver-sus the same concomitant chemoradiotherapy in patients with naso-pharyngeal carcinoma : a randomized phase II study conducted bythe Hellenic Cooperative Oncology Group (HeCOG) with biomark-er evaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
14Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradio- therapy in patients with nasopharyngeal carcinoma: A randomized phase II study conducted by the Hellenic Co- operative Oncology Group (HeCOG) with biomarker e- valuation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
15Multicenter phase-IItrial of irinotecan plus oxaliplatin in patients withpoor-prognosis cancer of unknown primary: a hellenic cooperativeoncology group study 显示文摘Briasoulis E Fountzilas G Bamias A 2008Cancer Chemother Pharmacol2008,62,2:1
16Car- boplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer 显示文摘Konstantinopoulos PA Fountzilas E Pillay K 2008BMC Med Genomics2008,1,:1
17Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer显示文摘KONSTANTINOPOULOS PA FOUNTZILAS E PILLAY K 2008BMC Med Genomics2008,1,:1
18Primary treatment of low-grade non Hodgkin's lymphomawith the combination of fludarabine and mitoxantrone:a phase II stud y of the Hellenic Cooperative Oncology Group显示文摘DimopoulosMA Fountzilas G Papageorgiou E 2002Leuk Lym p boma2002,43,1:1
19Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer 显示文摘KONSTANTINOPOULOS PA FOUNTZILAS E PILLAY K 2009Bmc Med Genomics2009,11,1:1
20Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer:a Hellenic Cooperative Oncology Group PhaseⅢStudy显示文摘Fountzilas G Ciuleanu E Dafni U 2004Med Oncol2004,21,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费